Appen Limited (ASX:APX) Releases Q1 FY25 Performance Report
Appen Limited (ASX:APX) reports Q1 FY25 revenue of $50.2M, improved EBITDA loss, and a strong cash position.

Appen Limited (ASX:APX) reports Q1 FY25 revenue of $50.2M, improved EBITDA loss, and a strong cash position.
Sparc Technologies Limited (ASX: SPN) releases its March 2025 Quarterly Report, highlighting advancements in green hydrogen and graphene-based additives alongside key corporate and financial updates.
Ionic Rare Earths (ASX: IXR) reports significant progress in magnet recycling and heavy rare earth projects, reducing CO₂ emissions.
EOS (ASX:EOS) announces significant business restructuring, portfolio divestments, and financial repayments as part of its ongoing turnaround strategy.
Mesoblast Limited (ASX:MSB) reports Q1 2025 milestones, including the US launch of Ryoncil® and strong financial performance.
Aurora Labs (ASX:A3D) completes development of the AU4 micro gas turbine, advancing production and defence sector engagements.
4DS Memory (ASX:4DS) reports Q1 2025 progress, including technical advancements and increased cash reserves.
NOVONIX Limited (ASX:NVX) finalizes a $5 million land purchase in Chattanooga, expanding production capacity and creating up to 500 jobs.
EMVision Medical Devices Limited (ASX:EMV) has commenced pivotal clinical trials for its emu™ brain scanner and announced successful device testing and robust cash reserves.
Duxton Farms (ASX:DBF) reports Q3 FY2025 activities, including strategic land acquisitions and significant asset sales to support growth and shareholder returns.